General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Daiichi Sankyo(MODEST), Boston Scientific Corporation(MODEST), Invitae(MODEST), Medtronic(MODEST), Abbott Laboratories(MODEST), Bristol Myers Squibb(SIGNIFICANT), UpToDate(MODEST), Tenaya Therapeutics(MODEST), Solid Biosciences(SIGNIFICANT) OTHER FINANCIAL BENEFIT: AliveCor(SIGNIFICANT), ARMGO Pharma(SIGNIFICANT), Pfizer(SIGNIFICANT), Anumana(NONE), Mayo Clinic(NONE), Thryv Therapeutics(SIGNIFICANT)
